Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Treated with Neoadjuvant Chemotherapy”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Testing effectiveness (Phase 2)Study completedNCT02307227
What this trial is testing

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

Who this might be right for
Breast Neoplasms
Centro di Riferimento Oncologico - Aviano 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710666
What this trial is testing

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

Who this might be right for
HER2-positive Breast Cancer
Cancer Trials Ireland 11
Not applicableStudy completedNCT00808041
What this trial is testing

Chemotherapy Monitoring With Breast Computed Tomography (CT)

Who this might be right for
Breast Cancer
Emory University 3
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Not applicableStudy completedNCT00033397
What this trial is testing

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 360
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06470633
What this trial is testing

To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer

Who this might be right for
Breast CancerHR+/HER2- Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 29
Large-scale testing (Phase 3)Study completedNCT00512993
What this trial is testing

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 654
Large-scale testing (Phase 3)UnknownNCT03359694
What this trial is testing

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

Who this might be right for
Susceptibility, GeneticChemotherapy Effect
Tianjin Medical University Cancer Institute and Hospital 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06691594
What this trial is testing

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

Who this might be right for
Breast Cancer Invasive
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Early research (Phase 1)UnknownNCT05755581
What this trial is testing

Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

Who this might be right for
Female Breast Cancer
Sohag University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT03595592
What this trial is testing

Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer

Who this might be right for
Invasive Breast Cancer
Fondazione Michelangelo 650
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05862610
What this trial is testing

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

Who this might be right for
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150
Testing effectiveness (Phase 2)UnknownNCT05400993
What this trial is testing

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

Who this might be right for
Breast Cancer
Shengjing Hospital 59
Not applicableWithdrawnNCT00934401
What this trial is testing

Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
University of Iowa
Testing effectiveness (Phase 2)Ended earlyNCT02795572
What this trial is testing

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Who this might be right for
Peripheral Neuropathy in Breast Cancer Patient
AHS Cancer Control Alberta 13
Not applicableStudy completedNCT06464341
What this trial is testing

Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 583
Testing effectiveness (Phase 2)Ended earlyNCT00462865
What this trial is testing

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Who this might be right for
Breast Cancer
Brown University 18
Testing effectiveness (Phase 2)Study completedNCT06513364
What this trial is testing

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., Ltd 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT05388500
What this trial is testing

Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C)

Who this might be right for
HER2-positive Breast Cancer
Institut de cancérologie Strasbourg Europe 800
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Load More Results